120 related articles for article (PubMed ID: 34653680)
1. ELP2 compound heterozygous variants associated with cortico-cerebellar atrophy, nodular heterotopia and epilepsy: Phenotype expansion and review of the literature.
Russo A; Forest C; Leone GJ; Iascone M; Tenconi R; Maffei M; Cersosimo A; Cordelli DM; Suppiej A
Eur J Med Genet; 2021 Dec; 64(12):104361. PubMed ID: 34653680
[TBL] [Abstract][Full Text] [Related]
2. ELP2 is a novel gene implicated in neurodevelopmental disabilities.
Cohen JS; Srivastava S; Farwell KD; Lu HM; Zeng W; Lu H; Chao EC; Fatemi A
Am J Med Genet A; 2015 Jun; 167(6):1391-5. PubMed ID: 25847581
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular findings in a Turkish family with an ultra-rare condition, ELP2-related neurodevelopmental disorder.
Dogan M; Teralı K; Eroz R; Demirci H; Kocabay K
Mol Biol Rep; 2021 Jan; 48(1):701-708. PubMed ID: 33393008
[TBL] [Abstract][Full Text] [Related]
4. A Novel
Turkyilmaz A; Sager G
Mol Syndromol; 2020 Dec; 11(5-6):315-319. PubMed ID: 33510603
[TBL] [Abstract][Full Text] [Related]
5. De Novo KAT5 Variants Cause a Syndrome with Recognizable Facial Dysmorphisms, Cerebellar Atrophy, Sleep Disturbance, and Epilepsy.
Humbert J; Salian S; Makrythanasis P; Lemire G; Rousseau J; Ehresmann S; Garcia T; Alasiri R; Bottani A; Hanquinet S; Beaver E; Heeley J; Smith ACM; Berger SI; Antonarakis SE; Yang XJ; Côté J; Campeau PM
Am J Hum Genet; 2020 Sep; 107(3):564-574. PubMed ID: 32822602
[TBL] [Abstract][Full Text] [Related]
6. A novel ELP1 mutation impairs the function of the Elongator complex and causes a severe neurodevelopmental phenotype.
Kojic M; Abbassi NEH; Lin TY; Jones A; Wakeling EL; Clement E; Nakou V; Singleton M; Dobosz D; Kaliakatsos M; Glatt S; Wainwright BJ
J Hum Genet; 2023 Jul; 68(7):445-453. PubMed ID: 36864284
[TBL] [Abstract][Full Text] [Related]
7. Epilepsy or neurodevelopmental disorders are associated with homozygous and pathogenic
Khalilov D; Haryanyan G; Salman B; Yucesan E; Ugur Iseri S; Bebek N
Neurocase; 2022 Dec; 28(6):488-492. PubMed ID: 36787709
[TBL] [Abstract][Full Text] [Related]
8. Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype.
Kojic M; Gawda T; Gaik M; Begg A; Salerno-Kochan A; Kurniawan ND; Jones A; Drożdżyk K; Kościelniak A; Chramiec-Głąbik A; Hediyeh-Zadeh S; Kasherman M; Shim WJ; Sinniah E; Genovesi LA; Abrahamsen RK; Fenger CD; Madsen CG; Cohen JS; Fatemi A; Stark Z; Lunke S; Lee J; Hansen JK; Boxill MF; Keren B; Marey I; Saenz MS; Brown K; Alexander SA; Mureev S; Batzilla A; Davis MJ; Piper M; Bodén M; Burne THJ; Palpant NJ; Møller RS; Glatt S; Wainwright BJ
Nat Commun; 2021 May; 12(1):2678. PubMed ID: 33976153
[TBL] [Abstract][Full Text] [Related]
9. Expanding the Phenotype of Homozygous
Yeşil G; Aralaşmak A; Akyüz E; İçağasıoğlu D; Uygur Şahin T; Bayram Y
Balkan Med J; 2018 Jul; 35(4):336-339. PubMed ID: 29545233
[TBL] [Abstract][Full Text] [Related]
10. The Elp2 subunit is essential for elongator complex assembly and functional regulation.
Dong C; Lin Z; Diao W; Li D; Chu X; Wang Z; Zhou H; Xie Z; Shen Y; Long J
Structure; 2015 Jun; 23(6):1078-86. PubMed ID: 25960406
[TBL] [Abstract][Full Text] [Related]
11. Bi-allelic Variants in the GPI Transamidase Subunit PIGK Cause a Neurodevelopmental Syndrome with Hypotonia, Cerebellar Atrophy, and Epilepsy.
Nguyen TTM; Murakami Y; Mobilio S; Niceta M; Zampino G; Philippe C; Moutton S; Zaki MS; James KN; Musaev D; Mu W; Baranano K; Nance JR; Rosenfeld JA; Braverman N; Ciolfi A; Millan F; Person RE; Bruel AL; Thauvin-Robinet C; Ververi A; DeVile C; Male A; Efthymiou S; Maroofian R; Houlden H; Maqbool S; Rahman F; Baratang NV; Rousseau J; St-Denis A; Elrick MJ; Anselm I; Rodan LH; Tartaglia M; Gleeson J; Kinoshita T; Campeau PM
Am J Hum Genet; 2020 Apr; 106(4):484-495. PubMed ID: 32220290
[TBL] [Abstract][Full Text] [Related]
12. Severe epileptic encephalopathy associated with compound heterozygosity of THG1L variants in the Ashkenazi Jewish population.
Rabin R; Hirsch Y; Johansson MM; Ekstein J; Ekstein A; Pappas J
Am J Med Genet A; 2021 May; 185(5):1589-1597. PubMed ID: 33682303
[TBL] [Abstract][Full Text] [Related]
13. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy.
Reinson K; Õiglane-Shlik E; Talvik I; Vaher U; Õunapuu A; Ennok M; Teek R; Pajusalu S; Murumets Ü; Tomberg T; Puusepp S; Piirsoo A; Reimand T; Õunap K
Am J Med Genet A; 2016 Aug; 170(8):2173-6. PubMed ID: 27250579
[TBL] [Abstract][Full Text] [Related]
14. Severe intellectual disability, absence of language, epilepsy, microcephaly and progressive cerebellar atrophy related to the recurrent de novo variant p.(P139L) of the CAMK2B gene: A case report and brief review.
Rizzi S; Spagnoli C; Salerno GG; Frattini D; Caraffi SG; Trimarchi G; Moratti C; Pascarella R; Garavelli L; Fusco C
Am J Med Genet A; 2020 Nov; 182(11):2675-2679. PubMed ID: 32875707
[TBL] [Abstract][Full Text] [Related]
15. Monoallelic and Biallelic Variants in EMC1 Identified in Individuals with Global Developmental Delay, Hypotonia, Scoliosis, and Cerebellar Atrophy.
Harel T; Yesil G; Bayram Y; Coban-Akdemir Z; Charng WL; Karaca E; Al Asmari A; Eldomery MK; Hunter JV; Jhangiani SN; Rosenfeld JA; Pehlivan D; El-Hattab AW; Saleh MA; LeDuc CA; Muzny D; Boerwinkle E; ; Gibbs RA; Chung WK; Yang Y; Belmont JW; Lupski JR
Am J Hum Genet; 2016 Mar; 98(3):562-570. PubMed ID: 26942288
[TBL] [Abstract][Full Text] [Related]
16. A patient with pontocerebellar hypoplasia type 6: Novel RARS2 mutations, comparison to previously published patients and clinical distinction from PEHO syndrome.
Nevanlinna V; Konovalova S; Ceulemans B; Muona M; Laari A; Hilander T; Gorski K; Valanne L; Anttonen AK; Tyynismaa H; Courage C; Lehesjoki AE
Eur J Med Genet; 2020 Mar; 63(3):103766. PubMed ID: 31536827
[TBL] [Abstract][Full Text] [Related]
17. De novo POLR2A p.(Ile457Thr) variant associated with early-onset encephalopathy and cerebellar atrophy: expanding the phenotypic spectrum.
Giacomini T; Scala M; Nobile G; Severino M; Tortora D; Nobili L; Accogli A; Torella A; Capra V; Mancardi MM; Nigro V;
Brain Dev; 2022 Aug; 44(7):480-485. PubMed ID: 35461703
[TBL] [Abstract][Full Text] [Related]
18. Extending the clinical phenotype of SPTAN1: From DEE5 to migraine, epilepsy, and subependymal heterotopias without intellectual disability.
Marco Hernández AV; Caro A; Montoya Filardi A; Tomás Vila M; Monfort S; Beseler Soto B; Nieto-Barceló JJ; Martínez F
Am J Med Genet A; 2022 Jan; 188(1):147-159. PubMed ID: 34590414
[TBL] [Abstract][Full Text] [Related]
19. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
20. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
Chemin J; Siquier-Pernet K; Nicouleau M; Barcia G; Ahmad A; Medina-Cano D; Hanein S; Altin N; Hubert L; Bole-Feysot C; Fourage C; Nitschké P; Thevenon J; Rio M; Blanc P; Vidal C; Bahi-Buisson N; Desguerre I; Munnich A; Lyonnet S; Boddaert N; Fassi E; Shinawi M; Zimmerman H; Amiel J; Faivre L; Colleaux L; Lory P; Cantagrel V
Brain; 2018 Jul; 141(7):1998-2013. PubMed ID: 29878067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
